Scientists at Rice University have developed a method to control the infectivity of viruses and gene delivery to the nuclei of target cells.
Scientists at Rice University have developed a method that uses light to control the infectivity of viruses and gene delivery to the nuclei of target cells. The method uses two shades of red light to control the level and spatial distribution of gene expression in cells via an engineered virus.
"Viruses in general are relatively efficient at delivering genes into cells, but they still experience great limiting barriers," said Junghae Suh, a Bioengineer at the Rice University labs, in a press release. "If you add these viruses to cells, most of them seem to hang out outside of the nucleus, and only a small fraction make their way inside, which is the goal."
The scientists at Rice built custom adeno-associated virus (AAV) vectors by incorporating proteins that naturally come together when exposed to red light, and break apart when exposed to far red. These naturally light-responsive proteins help the viral capsids-the hard shells that contain genetic payloads-enter the host cell nuclei.
"Light is really nice because you can apply it externally and you can control many aspects: at what areas the light is exposed, the duration of exposure, the intensity of the light and, of course, its wavelength," Suh said.
The protein pair comprises phytochrome B and its binding partner phytochrome interacting factor 6 (PIF6), found in thale cress. The researchers generated host cells that express phytochrome B tagged with a nuclear localization sequence, a small peptide known to help shuttle proteins into the nucleus more effectively. The smaller PIF6 was then attached to the outside surface of the virus capsid. This is the first time optogenetic proteins have been used to control the infectivity of viruses.
"When the viruses get internalized into a host cell, they accumulate around the nucleus naturally," Suh said. "Under nonactivated conditions, most of the viruses are stuck there. But when we shine activating red light on the cells, these two plant proteins dimerize-they come together-and because of the nuclear localization tag on the phytochrome B, the virus is dragged into the nucleus."
According to Suh, the platform may be used in the future to control what cells and tissues express, and at what level. The strategy could also find use in tissue-engineering applications like bioscaffolds for implantation.
Source: Rice University
Benuvia Granted GMP Certification by Brazil National Health Surveillance Agency
March 14th 2025The certification allows Benuvia to produce pharmaceutical products for companies, either local to Brazil or international, that may be looking for compliant and high-quality production capabilities in the Brazilian pharmaceutical market.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.